Literature DB >> 17453198

Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.

Maneesh Jain, Ganesh Venkatraman, Surinder K Batra.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17453198     DOI： 10.1007/s00259-007-0395-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

Review 1.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.

Authors:  Bhawna Gupta; Tatiana S Levchenko; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2004-12-22       Impact factor: 15.470

2.  Distribution of immunoglobulin Fab fragment conjugated with HIV-1 REV peptide following intravenous administration in rats.

Authors:  Shouju Kameyama; Ritsuko Okada; Takeo Kikuchi; Takao Omura; Ikuhiko Nakase; Toshihide Takeuchi; Yukio Sugiura; Shiroh Futaki
Journal:  Mol Pharm       Date:  2006 Mar-Apr       Impact factor: 4.939

3.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Authors:  H Nagahara; A M Vocero-Akbani; E L Snyder; A Ho; D G Latham; N A Lissy; M Becker-Hapak; S A Ezhevsky; S F Dowdy
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

4.  Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.

Authors:  D C Anderson; E Nichols; R Manger; D Woodle; M Barry; A R Fritzberg
Journal:  Biochem Biophys Res Commun       Date:  1993-07-30       Impact factor: 3.575

5.  Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

6.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

7.  Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides.

Authors:  Uwe Niesner; Cornelia Halin; Luisa Lozzi; Maja Günthert; Paolo Neri; Heidi Wunderli-Allenspach; Luciano Zardi; Dario Neri
Journal:  Bioconjug Chem       Date:  2002 Jul-Aug       Impact factor: 4.774

8.  Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein.

Authors:  A M Vocero-Akbani; N V Heyden; N A Lissy; L Ratner; S F Dowdy
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

9.  MTS-conjugated-antiactive caspase 3 antibodies inhibit actinomycin D-induced apoptosis.

Authors:  Y Zhao; T L Brown; H Kohler; S Müller
Journal:  Apoptosis       Date:  2003-12       Impact factor: 4.677

10.  Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin.

Authors:  Ekaterina Dadachova; Joshua D Nosanchuk; Li Shi; Andrew D Schweitzer; Annie Frenkel; Jerome S Nosanchuk; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205
View more
  3 in total

Review 1.  Cancer-associated mucins: role in immune modulation and metastasis.

Authors:  Rakesh Bhatia; Shailendra K Gautam; Andrew Cannon; Christopher Thompson; Bradley R Hall; Abhijit Aithal; Kasturi Banerjee; Maneesh Jain; Joyce C Solheim; Sushil Kumar; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

2.  The synergistic radiosensitizing effect of tirapazamine-conjugated gold nanoparticles on human hepatoma HepG2 cells under X-ray irradiation.

Authors:  Xi Liu; Yan Liu; Pengcheng Zhang; Xiaodong Jin; Xiaogang Zheng; Fei Ye; Weiqiang Chen; Qiang Li
Journal:  Int J Nanomedicine       Date:  2016-07-28

Review 3.  Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy.

Authors:  Veerle Kersemans; Bart Cornelissen
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.